Home » Topics » Regulatory » Patents

Patents
RSS

New orexin receptor antagonists disclosed by Merck & Co.

Feb. 25, 2015

Takeda patent reveals prokineticin PKR1 receptor antagonists

Feb. 25, 2015

Galapagos patents CFTR modulators

Feb. 25, 2015

Isis reports chemically modified ssASOs targeting ataxin-3

Feb. 25, 2015

U. S. researchers develop recombinant N. meningitidis factor H binding proteins

Feb. 25, 2015

Plasma kallikrein inhibitors disclosed in Kalvista Pharmaceuticals patent

Feb. 25, 2015

Boehringer Ingelheim presents new ROR-gamma modulators

Feb. 24, 2015

Sunshine Lake Pharma discloses new 5-HT reuptake inhibitors

Feb. 24, 2015

Merck & Co. patents new ROMK channel blockers

Feb. 24, 2015

Gruenenthal divulges novel PDE4B inhibitors

Feb. 24, 2015

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...